Pre-treatment with low-dose endotoxin prolongs survival from experimental lethal endotoxic shock: Benefit for lethal peritonitis by Escherichia coli

Cytokine

Volumn 62, Issue 3, 2013, Pages 382-388

  Kopanakis, Konstantinos ^a   Tzepi, Ira Maria ^a   Pistiki, Aikaterini ^a   Carrer, Dionyssia Pinelopi ^a   Netea, Mihai G ^b   Georgitsi, Marianna ^a   Lymperi, Maria ^a   Droggiti, Dionyssia Irini ^a   Liakakos, Theodoros ^a   Machairas, Anastasios ^a   Giamarellos Bourboulis, Evangelos J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; IL 17; LPS; Reprogramming; TREM 1

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 17; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; TREM1 PROTEIN, MOUSE;

ACCLIMATIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PERITONITIS; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; ESCHERICHIA COLI; IMMUNE RESPONSE; INNATE IMMUNITY; LIMIT OF DETECTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; SPLEEN CELL; SURVIVAL RATE; UPREGULATION; ANIMAL; APOPTOSIS; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; ESCHERICHIA COLI INFECTION; KAPLAN MEIER METHOD; LYMPHOCYTE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PERITONITIS; SPLEEN;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS;

ANIMALS; APOPTOSIS; CYTOKINES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; KAPLAN-MEIER ESTIMATE; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PERITONITIS; RECEPTORS, IMMUNOLOGIC; SHOCK, SEPTIC; SPLEEN;

EID: 84877812871     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.03.028     Document Type: Article

References (16)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Wang H., Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008, 26:711-715.
3. Giamarellos-Bourboulis E.J., van de Veerdonk F., Mouktaroudi M., Raftogiannis M., Antonopoulou A., Joosten L.A.B., et al. Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia. Crit Care 2011, 15:R27.
4. Biswas S.K., Lopwez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trend Immunol 2009, 30:475-482.
5. Mendez C., Kramer A., Salhab K., Valdes G., Norman G., Tracey K., et al. Tolerance to shock: an exploration of mechanism. Ann Surg 1999, 229:843-850.
6. Melo E.S., Barbeiro D.F., Gorjǎo R., Correia Sarmaento Rios E., Vasconelos D., Velasco I.T., et al. Gene expression reprogramming protects macrophage from sepsis-induced cell death. Mol Immunol 2010, 47:2587-2593.
7. Melo E.S., Goloubkova T., Barbeiro D.F., Gorjǎo R., Vasconelos D., Szabo C., et al. Endotoxin tolerance: selective alterations in gene expression and protection against lymphocyte death. Immunobiology 2010, 215:435-442.
8. Colonna M., Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis 2003, 187(Suppl. 2):S397-S401.
9. MacFie J. Current status of bacterial translocation as a cause of surgical sepsis. Br Med Bull 2004, 71:1-11.
10. Murphey E.D., Fang G., Sherwood E.R. Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Staphylococcus aureus. Crit Care Med 2008, 36:3067-3073.
11. Cua D.J., Tato C.M. Innate IL-17 producing cells: the sentinels of the immune system. Nat Rev Immunol 2010, 10:479-489.
12. Wesche D.E., Lomas-Neira J.L., Perl M., Chung C.S., Ayala A. Leucocyte apoptosis and its significance in sepsis and shock. J Leukocyte Biol 2005, 78:325-337.
13. Unsinger J., McDonough J.S., Shultz L.D., Ferguson T.A., Hotchkiss R.S. Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice. J Leukocyte Biol 2009, 86:219-227.
14. de Vos A.F., Pater J.M., van den Pangaart P.S., de Kruif M.D., van't Veer C., van der Poll T. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol 2009, 183:533-542.
15. Wheeler D.S., Lahni P.M., Denenberg A.G., Poynter S.E., Wong H.R., Cook J.A., et al. Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 2008, 30:267-273.
16. Lenz A.M., Qada M., Gardner S.A., Cheadle W.G. Impact of microbial tolerance in persistent secondary Klebsiella pneumoniae peritonitis. Cytokine 2011, 53:84-93.